从Kite Pharma公司在嵌合抗原受体T细胞领域的专利布局看国外药企的专利布局策略

Analysis the patent layout strategy of foreign pharmaceutical companies in the field of chimeric antigen receptor T cell therapy:taking Kite Pharma company as an example

创新药物研发企业对专利布局和专利保护有着强烈的需求。嵌合抗原受体T细胞(CAR⁃T)疗法作为近年来肿瘤等严重疾病治疗的主流发展方向,在全球范围内得到了广泛的研究,Kite Pharma公司作为该领域领先的制药企业,在全球范围内进行了全面的专利布局。本文通过梳理Kite Pharma公司在CAR⁃T领域的相关专利,深入剖析Kite Pharma公司专利布局与产品管线和商业发展的关系,以期能够为我国相关创新主体在该领域的产业发展路线和专利布局提供参考与启示。

New drug discovery companies have a strong demand for patent layout and patent protection.chimeric antigen receptor T cell(CAR⁃T)therapy,as the mainstream development direction of the treatment of serious diseases such as tumors,has been extensively studied around the world in recent years.As a leading pharmaceutical company in this field,Kite Pharma has carried out a comprehensive patent layout on a global scale.By sorting out Kite Pharma's patents in the field of CAR⁃T,the strategy of Kite Pharma's patent layout was analyzed from multiple dimensions.The relationship between Kite Pharma's patent layout and registered drugs as well as business development was analyzed,to provide reference and inspiration of the industrial development route and patent layout for innovative subjects in this field.